Literature DB >> 23749003

A 32-gene risk index: a new prognostic approach for prostate cancer progression.

Chao Cai1, Wei-De Zhong, W Scott McDougal, Chin-Lee Wu.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23749003      PMCID： PMC3881634          DOI： 10.1038/aja.2013.85

Source DB:  PubMed          Journal:  Asian J Androl        ISSN： 1008-682X            Impact factor:   3.285


× No keyword cloud information.
  8 in total

1.  Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911).

Authors:  Michel Bolla; Hein van Poppel; Bertrand Tombal; Kris Vekemans; Luigi Da Pozzo; Theo M de Reijke; Antony Verbaeys; Jean-François Bosset; Roland van Velthoven; Marc Colombel; Cees van de Beek; Paul Verhagen; Alphonsus van den Bergh; Cora Sternberg; Thomas Gasser; Geertjan van Tienhoven; Pierre Scalliet; Karin Haustermans; Laurence Collette
Journal:  Lancet       Date:  2012-10-19       Impact factor: 79.321

Review 2.  Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience.

Authors:  M Han; A W Partin; C R Pound; J I Epstein; P C Walsh
Journal:  Urol Clin North Am       Date:  2001-08       Impact factor: 2.241

3.  Men with organ-confined prostate cancer and positive surgical margins develop biochemical failure at a similar rate to men with extracapsular extension.

Authors:  Sarah P Psutka; Adam S Feldman; David Rodin; Aria F Olumi; Chin-Lee Wu; W Scott McDougal
Journal:  Urology       Date:  2011-03-16       Impact factor: 2.649

4.  Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition.

Authors:  Andrew J Stephenson; Michael W Kattan; James A Eastham; Zohar A Dotan; Fernando J Bianco; Hans Lilja; Peter T Scardino
Journal:  J Clin Oncol       Date:  2006-08-20       Impact factor: 44.544

5.  Quantitative detection of micrometastases in pelvic lymph nodes in patients with clinically localized prostate cancer by real-time reverse transcriptase-PCR.

Authors:  Hideaki Miyake; Isao Hara; Toshifumi Kurahashi; Taka-aki Inoue; Hiroshi Eto; Masato Fujisawa
Journal:  Clin Cancer Res       Date:  2007-02-15       Impact factor: 12.531

6.  Development and validation of a 32-gene prognostic index for prostate cancer progression.

Authors:  Chin-Lee Wu; Brock E Schroeder; Xiao-Jun Ma; Christopher J Cutie; Shulin Wu; Ranelle Salunga; Yi Zhang; Michael W Kattan; Catherine A Schnabel; Mark G Erlander; W Scott McDougal
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-26       Impact factor: 11.205

7.  Cancer statistics, 2013.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2013-01-17       Impact factor: 508.702

Review 8.  The clinical usefulness of prostate specific antigen: update 1994.

Authors:  A W Partin; J E Oesterling
Journal:  J Urol       Date:  1994-11       Impact factor: 7.450
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.